NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. 

Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes.

NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world.   From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets.

In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies.

NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”. 


Life Sciences

Pharmaceutical

NS Pharma, Inc.

Yoshihiko Makita

Manabu Beppu

Koji Kimura

Tatsuaki Morokata

Takeshi Seita

Leslie Magnus

Gardner Gendron

The Clinical Research and Regulatory Affairs team at NS Pharma, Inc. is responsible for overseeing the design, implementation, and management of clinical trials, ensuring the development of safe and effective pharmaceuticals. This team collaborates closely with global partners and regulatory bodies to navigate the complexities of drug development and compliance, facilitating the successful introduction of innovative drug candidates from Japan and Asia to the global market. By integrating clinical research with regulatory strategies, the team strives to enhance patient care and support NSP's mission of delivering high-quality pharmaceutical solutions.

Clinical Research and Regulatory Affairs

Patient Access and Market Engagement

Leadership Team

Clinical Research and Regulatory Affairs

About

Team members

Other teams at NS Pharma, Inc.

Patient Access and Market Engagement

Leadership Team